Dapagliflozin (5mg), Vildagliptin SR (50mg) .........

Dapagliflozin (5mg), Vildagliptin SR (50mg)
DAPA VILDA 50/5  
Dapagliflozin is a medication that belongs to the class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors.
It works by inhibiting the SGLT2 protein in the kidneys. SGLT2 is responsible for reabsorbing glucose from the urine into the bloodstream. By inhibiting this protein, dapagliflozin allows excess glucose to be excreted in the urine, which helps lower blood sugar levels.
Vildagliptin is a medication that belongs to the class of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors.
It works by inhibiting the DPP-4 enzyme, which degrades hormones called incretins (glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide). Incretins help regulate blood sugar levels by stimulating the release of insulin and reducing the release of glucagon after meals.
Vildagliptin is typically used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/dapa-vilda-50-5-134374